-
BARDA Awards Contract to DNAe to Develop Semiconductor DNA Sequencing Platform
Bio-IT World Brief | DNAe announced that BARDA has awarded the company a contract worth up to $51.9 million to develop its sequencing platform for rapid diagnosis in two key applications; antimicrobial resistant infections and influenza.
Oct 3, 2016
-
Oxford Nanopore’s Plans for Pre-Packaged Cas9 Test Kits
Bio-IT World | Oxford Nanopore Technologies is seeing more of a demand to focus on a subset of input materials, Clive Brown said this morning in his technical update. In addition to new pores, new chemistries, and updates on various devices, Brown dove into a Cas9 application that the company has been exploring and intimated that Oxford Nanopore will soon begin selling specific test kits for its mobile sequencers.
Sep 29, 2016
-
Oxford Nanopore Announces New Pores, Kits and Updates on Projects
Bio-IT World | The Chief Technology Officer at Oxford Nanopore gave a technical Oxford Nanopore update this morning, outlining updates on MinION, PromethION, SmidgeION, hardware and chemistries.
Sep 29, 2016
-
Cloud Pharmaceuticals, Rubicon Genomics, Bioz and more: News from September 2016
Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Cloud Pharmaceuticals, Rubicon Genomics, Bioz, and more.
Sep 29, 2016
-
Despite the Hype Over Gene Therapy Few Drugs Are Close to Approval
MIT Technology Review | There are hundreds of early clinical trials, but only a handful of late-stage ones have reached completion.
Sep 29, 2016
-
Why Big Pharma Wants To Collect 2 Million Genomes
Nature News & Comment | For the head of AstraZeneca's genomics initiative, the challenge is not just getting the sequences, but in putting them to use - wisely.
Sep 28, 2016
-
Microsoft Goes All in for FPGAs to Build Out AI Cloud
TOP500 Supercomputer Sites | Microsoft has revealed that Altera FPGAs have been installed across every Azure cloud server, creating what the company is calling "the world's first AI supercomputer."
Sep 28, 2016
-
Addressing Common Roadblocks In Drug Development: Keynotes At 2016 Discovery On Target
Bio-IT World | There is tremendous unlocked potential for new therapeutic drugs. Some of the key aspects of drug development were addressed with novel solutions in compelling plenary keynote talks at the 2016 Discovery on Target Conference in Boston last week.
Sep 28, 2016


